Back to search

France· FR:64722435

FEMARA 2,5 mg, comprimé pelliculé

A letrozole product containing létrozole, registered in France by BB FARMA (ITALIE), on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L02BG04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFEMARA 2,5 mg, comprimé pelliculéATCL02BG04REGISTER NO.FR:64722435PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Letrozole is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BG04 (letrozole), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose

Letrozole · ATC L02BG04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of letrozole costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.23 in France to $27.12 in United States — a ×22 gap.

  • France: $1.23 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Letrozole · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • US United States$27.12 (acquisition cost)
  • CH Switzerland$2.73
  • IT Italy$2.51
  • FR France$1.23
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LÉTROZOLE
Manufacturer
BB FARMA (ITALIE)
Country
France (FR)
ATC code
L02BG04
ATC class
Letrozole
Defined daily dose
2.5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400949000944
    plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)
    EUR 32.44

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

311 interactions on record for letrozole.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Letrozole · interactions on record

311 records

  • 2 severe
  • 93 moderate
  • 7 minor
  • 209 info

Most severe, free to view

  • ThalidomideL04AX02severe
  • CitalopramN06AB04severe
  • AprepitantA04AD12moderate
  • LonafarnibA16AX20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Letrozole in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All letrozole products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Femara, Letrofam
  • Belgium · Femara, Letrozol Sandoz
  • Bulgaria · Етрузил, Зеквипра
  • Cyprus · Femara, Feremazol
  • Czechia · Aletro, Dracenax
  • Germany · Femara, Letro-Cell
  • Denmark · Letrozol Accord, Letrozol Medical Valley
  • Estonia · Femara, Feremazol
  • Spain · Femara, Galdar
  • Finland · Femar, Letrolan
  • United Kingdom (Northern Ireland) · Femara, Letrozole
  • Greece · Femaplex, Femara
  • Croatia · Avomit, Femara
  • Hungary · Etruzil, Famos
  • Ireland · Femara, Letrozole Accord Healthcare Ireland
  • Iceland · Letromal, Letrozol Actavis
  • Italy · Blormat, Brestoral
  • Lithuania · Femara, Feremazol
  • Luxembourg · Femara, Letrozole Eg
  • Latvia · Femara, Letrozole Sanoswiss
  • Malta · Femara, Feremazol
  • Netherlands · Etruzil, Letrostar
  • Norway · Femar, Letrozol Accord
  • Poland · Aromek, Clarzole
  • Portugal · Femara, Letrozol Accord
  • Romania · Elozora, Etruzil
  • Sweden · Letrozol Accord, Letrozol Medical Valley
  • Slovenia · Femara, Letrozol Genthon
  • Slovakia · Aletro, Etruzil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c8599d99-2aa7-4b8b-af6d-ec04cbb9ff7d
GET /v1/drugs/c8599d99-2aa7-4b8b-af6d-ec04cbb9ff7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64722435",
  "date_amm": "2016-06-24",
  "type_amm": "Autorisation d'importation parallèle",
  "numero_ue": null,
  "substance": "LÉTROZOLE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about letrozole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.